Literature DB >> 17907815

Cognitive impairments in the STOP null mouse model of schizophrenia.

Kelly J Powell1, Sarah E Hori, Ronald Leslie, Annie Andrieux, Heather Schellinck, Michael Thorne, George S Robertson.   

Abstract

Cognitive dysfunction is a primary and persisting core deficit of schizophrenia that is marginally improved by antipsychotic treatment. Adult mice that lack the stable tubule-only polypeptide (STOP) have neurochemical and behavioral abnormalities that model some features of schizophrenia. Recognition and long-term memory in the STOP null mouse were tested with the novel object recognition task and an olfactory discrimination task, respectively. Researchers examined the brains from STOP null mice to determine whether differences in task performance were associated with alterations in brain morphology. STOP null mice displayed deficits in both recognition and long-term memory. These behavioral deficits were accompanied by a massive enlargement of the cerebral ventricular system as well as by reductions in volume of cortical and diencephalic structures. In addition to deficits in recognition and long-term memory, STOP null mice displayed exaggerated neuroanatomical deficits somewhat reminiscent of those observed among individuals with schizophrenia. (PsycINFO Database Record (c) 2007 APA, all rights reserved).

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17907815     DOI: 10.1037/0735-7044.121.5.826

Source DB:  PubMed          Journal:  Behav Neurosci        ISSN: 0735-7044            Impact factor:   1.912


  18 in total

1.  Nitric oxide synthase mediates the ability of darbepoetin alpha to improve the cognitive performance of STOP null mice.

Authors:  Kosuke Kajitani; Michael Thorne; Michel Samson; George S Robertson
Journal:  Neuropsychopharmacology       Date:  2010-03-24       Impact factor: 7.853

Review 2.  Basic Neuroscience Illuminates Causal Relationship Between Sleep and Memory: Translating to Schizophrenia.

Authors:  Ana Pocivavsek; Laura M Rowland
Journal:  Schizophr Bull       Date:  2018-01-13       Impact factor: 9.306

Review 3.  Effects of antipsychotic D2 antagonists on long-term potentiation in animals and implications for human studies.

Authors:  Rae Price; Bahar Salavati; Ariel Graff-Guerrero; Daniel M Blumberger; Benoit H Mulsant; Zafiris J Daskalakis; Tarek K Rajji
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2014-05-10       Impact factor: 5.067

4.  New horizons in schizophrenia treatment: autophagy protection is coupled with behavioral improvements in a mouse model of schizophrenia.

Authors:  Avia Merenlender-Wagner; Zeev Shemer; Olga Touloumi; Roza Lagoudaki; Eliezer Giladi; Annie Andrieux; Nikolaos C Grigoriadis; Illana Gozes
Journal:  Autophagy       Date:  2014       Impact factor: 16.016

5.  Chronic administration of atypical antipsychotics improves behavioral and synaptic defects of STOP null mice.

Authors:  David Delotterie; Geoffrey Ruiz; Jacques Brocard; Annie Schweitzer; Corinne Roucard; Yann Roche; Marie-Françoise Suaud-Chagny; Karine Bressand; Annie Andrieux
Journal:  Psychopharmacology (Berl)       Date:  2009-11-21       Impact factor: 4.530

6.  Neurobehavioral abnormalities in the dysbindin-1 mutant, sandy, on a C57BL/6J genetic background.

Authors:  M M Cox; A M Tucker; J Tang; K Talbot; D C Richer; L Yeh; S E Arnold
Journal:  Genes Brain Behav       Date:  2009-02-11       Impact factor: 3.449

7.  Neuregulin 1 transgenic mice display reduced mismatch negativity, contextual fear conditioning and social interactions.

Authors:  Richard S Ehrlichman; Steven N Luminais; Samantha L White; Noam D Rudnick; Nan Ma; Holly C Dow; Arati S Kreibich; Ted Abel; Edward S Brodkin; Chang-Gyu Hahn; Steven J Siegel
Journal:  Brain Res       Date:  2009-07-28       Impact factor: 3.252

8.  Disruptions of Sleep/Wake Patterns in the Stable Tubule Only Polypeptide (STOP) Null Mouse Model of Schizophrenia.

Authors:  Maxine F Profitt; Samuel Deurveilher; George S Robertson; Benjamin Rusak; Kazue Semba
Journal:  Schizophr Bull       Date:  2016-03-02       Impact factor: 9.306

9.  Altered circadian activity and sleep/wake rhythms in the stable tubule only polypeptide (STOP) null mouse model of schizophrenia.

Authors:  Samuel Deurveilher; Kristin Robin Ko; Brock St C Saumure; George S Robertson; Benjamin Rusak; Kazue Semba
Journal:  Sleep       Date:  2021-04-09       Impact factor: 5.849

Review 10.  The microtubule cytoskeleton at the synapse.

Authors:  Julie Parato; Francesca Bartolini
Journal:  Neurosci Lett       Date:  2021-03-26       Impact factor: 3.046

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.